# Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis

> **NCT07052981** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Guixia Ding** · enrollment: 124 (estimated)

## Conditions studied

- IgA Nephropathy (IgAN)
- IgAVN

## Interventions

- **DRUG:** Telitacicept

## Key facts

- **NCT ID:** NCT07052981
- **Lead sponsor:** Guixia Ding
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-06-30
- **Target enrollment:** 124 (ESTIMATED)
- **Last updated:** 2025-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07052981

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07052981, "Clinical Study on the Efficacy and Safety of Telitacicept in the Treatment of Pediatric IgA Nephropathy or IgA Vasculitis Nephritis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07052981. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*